Patents by Inventor Leonard E. Maroun

Leonard E. Maroun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Interferon antagonists useful for the treatment of interferon related diseases
    Patent number: 7887814
    Abstract: The present invention relates to a process for ameliorating or preventing diseases that are caused, in part, by an increased level of, and/or an abnormal responsivity to, interferon. Specifically, the invention provides compositions and methods for preventing and treating subjects suffering from, or at risk for, such diseases. Such methods include the administration of a pharmacological preparation of interferon binding proteins that antagonize interferon's action. This invention comprises compositions of interferon binding proteins that can inhibit the activity of Type I and II.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: February 15, 2011
    Assignee: Meiogen Biotechnology Corporation
    Inventor: Leonard E. Maroun
  • Interferon antagonists useful for the treatment of interferon related diseases
    Patent number: 7285526
    Abstract: The present invention relates to a process for ameliorating or preventing diseases that are caused, in part, by an increased level of, and/or an abnormal responsivity to, interferon. Alzheimer's disease, HIV infection, Down syndrome, transplant rejection, autoimmune disease, and infant encephalitis are examples of such diseases. Specifically, the invention provides a method for treating subjects suffering from, or at risk for, such diseases by the administration of a pharmacological preparation of interferon binding proteins of mammalian and/or viral origin that antagonize interferon's action. This invention comprises compositions of interferon binding proteins that can inhibit the activity of interferon gamma plus interferon alpha such compositions along with their method of production and modification being described herein.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: October 23, 2007
    Assignee: Meiogen Biotechnology Corporation
    Inventor: Leonard E. Maroun
  • Interferon antagonists useful for the treatment of interferon related diseases
    Publication number: 20030138404
    Abstract: The present invention relates to a process for ameliorating or preventing diseases that are caused, in part, by an increased level of, and/or an abnormal responsivity to, interferon. Alzheimer's disease, HIV infection, Down syndrome, transplant rejection, autoimmune disease, and infant encephalitis are examples of such diseases. Specifically, the invention provides a method for treating subjects suffering from, or at risk for, such diseases by the administration of a pharmacological preparation of interferon binding proteins of mammalian and/or viral origin that antagonize interferon's action. This invention comprises compositions of interferon binding proteins that can inhibit the activity of interferon gamma plus interferon alpha such compositions along with their method of production and modification being described herein.
    Type: Application
    Filed: October 31, 2002
    Publication date: July 24, 2003
    Applicant: Meiogen Biotechnology Corporation
    Inventor: Leonard E. Maroun
  • Methods of treatment of neurological diseases by interferon antagonists
    Publication number: 20030021764
    Abstract: The present invention relates to a process for ameliorating or preventing neurological diseases that are caused, in part, by an increased and/or abnormal responsivity to interferon. Specifically, the invention provides a method for treating subjects suffering from or at risk for such diseases by the administration of a pharmacological preparation that antagonizes interferons' action.
    Type: Application
    Filed: April 30, 2001
    Publication date: January 30, 2003
    Applicant: Meiogen Biotechnology Corporation
    Inventor: Leonard E. Maroun
  • Methods of treatment of down syndrome by interferon antagonists
    Patent number: 5780027
    Abstract: The present invention relates to a process for ameliorating or preventing neurological diseases that are caused, in part, by an increased and/or abnormal responsivity to interferon. Down Syndrome (DS) and Alzheimer's Disease (AD) are examples of such diseases. Specifically, the invention provides a method for treating subjects suffering from or at risk for such diseases by the administration of a pharmacological preparation that antagonizes interferon's action.
    Type: Grant
    Filed: July 14, 1995
    Date of Patent: July 14, 1998
    Assignee: Meiogen Biotechnology Corporation
    Inventor: Leonard E. Maroun